Journals / Selçuk Tıp Dergisi / 2019 / Cilt: 35 - Sayı: 1

Nursing Care According to Roy Adaptation Model in A Patient with Chemotherapy Treated Gastric Cancer

Kemoterapi Alan Mide Kanserli Bir Vakanın Roy Adaptasyon Modeli’ne Göre Hemşirelik Bakımı

Pages
58–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The model is thought to be available to patients receiving chemotherapy treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Gastric cancer is among the common cancers and chemotherapy is among the treatment plan.
📊
Key Findings & Data:Chemotherapy affects many systems, it is important for the individual and her environment to adapt to this process.
💡
Conclusion & Impact:The model is thought to be available to patients receiving chemotherapy treatment.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Gastric cancer is among the common cancers and chemotherapy is among the treatment plan. Chemotherapy affects many systems, it is important for the individual and her environment to adapt to this process. In order to improve this adaptation, the nursing care process given to the patient with gastric cancer who was receiving the first chemotherapy treatment according to the Roy Adaptation Model was described. According to the data obtained by the permission of the patient, impaired physical mobility, anxiety, deficient knowledge about chemotherapy treatment process, defensive coping, readiness for enhanced family coping, nursing diagnoses were made and appropriate nursing interventions were applied. The model is thought to be available to patients receiving chemotherapy treatment.

Özet

Mide kanseri sık görülen kanserler arasındadır ve kemoterapi tedavi planı arasında yer almaktadır. Birçok sistemi etkileyen bu tedavi yönteminde bireyin ve çevresinin bu sürece uyumu önemlidir. Bu uyumu artırmak amacıyla makalede Roy Adaptasyon Modeli’ne göre ilk kemoterapi kürünü almaya gelen mide kanserli hastaya verilen hemşirelik bakım süreci anlatılmıştır. Hastadan izin alınarak elde edilen veriler doğrultusunda hastaya; fiziksel harekette bozulma, anksiyete, kemoterapi tedavi sürecine yönelik bilgi eksikliği, bireysel baş etmede yetersizlik, aile içi süreçlerde güçlenmeye hazır oluş hemşirelik tanıları konulmuş, uygun hemşirelik girişimleri yapılmıştır. Modelin kemoterapi tedavisi alan hastalarda kullanılabilir olduğu düşünülmüştür.

🔖

Cite This Article

EREN, H., İSKENDER, M. D. (2019). Nursing Care According to Roy Adaptation Model in A Patient with Chemotherapy Treated Gastric Cancer. Selçuk Tıp Dergisi, Cilt: 35 - Sayı: 1, 58–62. https://ajindex.com/articles/319061

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in Globocan 2012. Int J Cancer 2015;136(5): E359- 86
  2. Yalçın B, Zengin N, Aydın F, et al. The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish oncology group study. Turk J Cancer 2006;36:108-15
  3. Meijer S, De Bakker Oj, Hoitsma HF. Palliative resebtion in gastric cancer. J Surg Oncol 1983;23(2):77-80
  4. Kurihara M, Aiko T. The new Japanese classification of gastric carcinoma: Revised explanation of “response assessment of chemotherapy and radiotherapy for gastric carcinoma.” Gastric Cancer 2001;4(1):9-13
  5. Thuss-Patience PC, Krezschmar A, Bıchev D, et al. Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer: A randomised phase III study of the arbeitsgemeinschaft internistische onkologie (AIO). Eur J Cancer 2011;47(15): 2306-14
  6. Kamen C, Tejani MA, Chandwani K, et al. Anticipatory nausea and vomiting due to chemotherapy. European J Pharma 2014;5(722):172-9
  7. Chan HK, İsmail S. Side effects of chemotherapy among cancer patients in a Malaysian general hospital: Experiences, perceptions and informational needs from clinical pharmacists. Asian Pac J Prev 2015;15(13): 5305-9
  8. Galluzzi L, Buque A, Kepp O, et al. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 2015;28(6):690-714
  9. Ünsar S, Fındık YÜ, Kurt S, et al. Kanserli hastalarda evde bakım ve semptom kontrolü. Fırat Sağlık Hizmetleri Dergisi 2007;2(5):89-106
  10. Fawcett J. Contemporary nursing knowledge analysis and evoulation of nursing models and theories. 2th ed. Philadelphia: Fa Davis company 2005:364-437
  11. Kaçaroğlu VA. Hemşirelik bakımında model kullanımına bir örnek: Modifiye radikal mastektomi olmuş bir bayanın, roy adaptasyon modeline göre incelenmesi. Maltepe Üniversitesi Bilim ve Sanat Dergisi 2010;2:106-18
  12. Uzun Ş. Hemşirelik teorileri ve modelleri. Karadağ A, Çalışkan N, Göçmen Baykara Z, ed. Sister callista roy: Adaptasyon modeli. Akademi basın ve yayıncılık, İstanbul 2017:370-437
  13. Roy C. The roy adaptation model. 3rd ed. New Jersey upper saddle river: Pearson Prentice Hall Health 2009:35-50
  14. Roy S. Extending the roy adaptation model to meet changing global needs. Nursing Science Quarterly 2011;24:345-51
  15. Ardashir A, Karimi Z, Hassani P. Roy’s adaptation model- based patient education for promo